Oral lactoferrin prevents body weight loss and increases cytokine responses during herpes simplex virus type 1 infection of mice

Bioscience, Biotechnology and Biochemistry

Volumn 68, Issue 3, 2004, Pages 537-544

  Wakabayashi, Hiroyuki ^a,b   Kurokawa, Masahiko ^b   Shin, Kouichirou ^a,b   Teraguchi, Susumu ^a   Tamura, Yoshitaka ^a   Shiraki, Kimiyasu ^b  

^a MORINAGA MILK INDUSTRY CO LTD   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Body weight; Cytokine; Herpes simplex virus type 1 (HSV 1); Homeostasis; Lactoferrin

Indexed keywords

CYTOKINE; LACTOFERRIN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; BODY WEIGHT; CELL COUNT; CULTURE TECHNIQUE; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; IMMUNOLOGY; MOUSE; ORAL DRUG ADMINISTRATION; SPLEEN;

ADMINISTRATION, ORAL; ANIMALS; CELL COUNT; CELL CULTURE TECHNIQUES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; LACTOFERRIN; MICE; MICE, INBRED BALB C; SPLEEN; THINNESS;

BOVINAE; HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 4544351650     PISSN: 09168451     EISSN: None     Source Type: Journal    
DOI: 10.1271/bbb.68.537     Document Type: Article

References (38)

1. Chierici, R., Antimicrobial actions of lactoferrin. Adv. Nutr. Res., 10, 247-269 (2001).
2. Brock, J., Lactoferrin: a multifunctional immunoregulatory protein? Immunol. Today, 16, 417-419 (1995).
3. Guillen, C., McInnes, I. B., Vaughan, D. M., Kommajosyula, S., Van Berkel, P. H. C., Leung, B. P., Aguila, A., and Brock, J. H., Enhanced Th1 response to Staphylococcus aureus infection in human lactoferrin-transgenic mice. J. Immunol., 168, 3950-3957 (2002).
4. van der Strate, B. W., Beljaars, L., Molema, G., Harmsen, M. C., and Meijer, D. K. F., Antiviral activities of lactoferrin. Antiviral Res., 52, 225-239 (2001).
5. Nozaki, A., Ikeda, M., Naganuma, A., Nakamura, T., Inudoh, M., Tanaka, K., and Kato, N., Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope protein. J. Biol. Chem., 278, 10162-10173 (2003).
6. Tomita, M., Wakabayashi, H., Yamauchi, K., Teraguchi, S., and Hayasawa, H., Bovine lactoferrin and lactoferricin derived from milk: production and applications. Biochem. Cell Biol., 80, 109-112 (2002).
7. Bhimani, R. S., Vendrov, Y., and Furmanski, P., Influence of lactoferrin feeding and injection against systemic staphylococcal infections in mice. J. Appl. Microbiol., 86, 135-144 (1999).
8. Haversen, L. A., Engberg, I., Baltzer, L., Dolphin, G., Hanson, L. A., and Mattsby-Baltzer, I., Human lactoferrin and peptides derived from surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice. Infect. Immun., 68, 5816-5823 (2000).
9. Wakabayashi, H., Uchida, K., Yamauchi, K., Teraguchi, S., Hayasawa, H., and Yamaguchi, H., Lactoferrin given in food facilitates dermatophytosis cure in guinea pig models. J. Antimicrob. Chemother., 46, 595-601 (2000).
10. Yamauchi, K., Hiruma, M., Yamazaki, N., Wakabayashi, H., Kuwata, H., Teraguchi, S., Hayasawa, H., Suegara, N., and Yamaguchi, H., Oral administration of bovine lactoferrin for treatment of tinea pedis. A placebo-controlled, double-blind study. Mycoses, 43, 197-202 (2000).
11. Isamida, T., Tanaka, T., Omata, Y., Yamauchi, K., Shimazaki, K., and Saito, A., Protective effects of lactoferricin against Toxoplasma gondii infection in mice. J. Vet. Med. Sci., 60, 241-244 (1998).
12. Tanaka, K., Ikeda, M., Nozaki, A., Kato, N., Tsuda, H., Saito, S., and Sekihara, H., Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: a pilot study. Jpn. J. Cancer Res., 90, 367-371 (1999).
13. Iwasa, M., Kaito, M., Ikoma, J., Takeo, M., Imoto, I., Adachi, Y., Yamauchi, K., Koizumi, R., and Teraguchi, S., Lactoferrin inhibits hepatitis C virus viremia in chronic hepatitis C patients with high viral loads and HGV genotype 1b. Am. J. Gastroenterol., 97, 766-767 (2002).
14. Okada, S., Tanaka, K., Sato, T., Ueno, H., Saito, S., Okusaka, T., Sato, K., Yamamoto, S., and Kakizoe, T., Dose-response trial of lactoferrin in patients with chronic hepatitis C. Jpn. J. Cancer Res., 93, 1063-1069 (2002).
15. Wakabayashi, H., Kuwata, H., Yamauchi, K., Teraguchi, S., and Tamura, Y., No detectable transfer of dietary lactoferrin or its functional fragments to portal blood in healthy adult rats. Biosci. Biotechnol. Biochem., in press.
16. Nakajima, M., Iwamoto, H., Shirasawa, T., Miyauchi, H., Takatsu, Z., Yamazaki, N., Teraguchi, S., and Hayasawa, H., Oral administration of lactoferrin enhances the productions of IFN-γ and IL-10 in spleen cells cultured with concanavalin A or lipopolysaccharide. Biomed. Res., 20, 27-33 (1999).
17. Kuhara, T., Iigo, M., Itoh, T., Ushida, Y., Sekine, K., Terada, N., Okamura, H., and Tsuda, H., Orally administered lactoferrin exerts an antimetastatic effect and enhances production of IL-18 in the intestinal epithelium. Nutr. Cancer, 38, 192-199 (2000).
18. Wakabayashi, H., Takakura, N., Yamauchi, K., Teraguchi, S., Uchida, K., Yamaguchi, H., and Tamura, Y., Effect of lactoferrin feeding on the host antifungal response in guinea pigs infected or immunized with Trichophyton mentagrophytes. J. Med. Microbiol., 51, 844-850 (2002).
19. Wakabayashi, H., Takakura, N., Teraguchi, S., and Tamura, Y., Lactoferrin feeding augments peritoneal macrophage activities in mice intraperitoneally injected with inactivated Candida albicans. Microbiol. Immunol., 47, 37-43 (2003).
20. Wang, W.-P., Iigo, M., Sato, J., Sekine, K., Adachi, I., and Tsuda, H., Activation of intestinal mucosal immunity in tumor-bearing mice by lactoferrin. Jpn. J. Cancer Res., 91, 1022-1027 (2000).
21. Hasegawa, K., Motsuchi, W., Tanaka, S., and Dosako, S., Inhibition with lactoferrin of in vitro infection with human herpes virus. Jpn. J. Med. Sci. Biol., 47, 73-85 (1994).
22. Marchetti, M., Longhi, C., Conte, M. P., Pisani, S., Velanti, P., and Seganti, L., Lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells. Antiviral Res., 29, 221-231 (1996).
23. Bellamy, W., Takase, M., Yamauchi, K., Wakabayashi, H., Kawase, K., and Tomita, M., Identification of the bactericidal domain of lactoferrin. Biochim. Biophys. Acta, 1121, 130-136 (1992).
24. Siciliano, R., Rega, B., Marchetti, M., Seganti, L., Antonini, G., and Valenti, P., Bovine lactoferrin peptidic fragments involved in inhibition of herpes simplex virus type 1 infection. Biochem. Biophys. Res. Commun., 264, 19-23 (1999).
25. Hammer, J., Haaheim, H., and Gutteberg, T. J., Bovine lactoferrin is more efficient than bovine lactoferricin in inhibiting HSV-I/-II replication in vitro. In "Lactoferrin: Structure, Function and Applications", eds. Shimazaki, K., Tsuda, H., Tomita, M., Kuwata, T., and Perraudin, J.-P., Elsevier Science, Amsterdam, pp. 239-243 (2000).
26. Andersen, J. H., Jenssen, H., and Gutteberg, T. J., Lactoferrin and lactoferricin inhibit herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir. Antiviral Res., 58, 209-215 (2003).
27. Fujihara, T., and Hayashi, K., Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea. Arch. Virol., 140, 1469-1472 (1995).
28. Kurokawa, M., Ochiai, H., Nagasaka, K., Neki, M., Xu, H., Kadota, S., Sutardjo, S., Matsumoto, T., Namba, T., and Shiraki, K., Antiviral traditional medicines against herpes simplex virus (HSV-1), poliovirus, and measles virus in vitro and their therapeutic efficacies for HSV-1 infection in mice. Antiviral Res., 22, 175-188 (1993).
29. Kurokawa, M., Hozumi, T., Tsurita, M., Kadota, S., Namba, T., and Shiraki, K., Biological characterization of eugeniin as an anti-herpes simplex virus type 1 compound in vitro and in vivo. J. Pharmacol. Exp. Ther., 297, 372-379 (2001).
30. Kruisbeek, A. M., Isolation and fractionation of mononuclear cell populations. In "Current Protocols in Immunology", John Wiley & Sons, New York, pp. 3.1.1-3.1.5. (1993).
31. Smith, P. M., Wolcott, R. M., Chervenak, R., and Jennings, S. R., Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma. Virology, 202, 76-88 (1994).
32. Kobayashi, H., Kobayashi, M., Utsunomiya, T., Herndon, D. N., Pollard, R. B., and Suzuki, F., Therapeutic protective effects of IL-12 combined with soluble IL-4 receptor against established infections of herpes simplex virus type 1 in thermally injured mice. J. Immunol., 162, 7148-7154 (1999).
33. Vollstedt, S., Franchini, M., Alber, G., Ackermann, M., and Suter, M., Interleukin-12- and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1. J. Virol., 75, 9596-9600 (2001).
34. Fujioka, N., Akazawa, R., Ohashi, K., Fujii, M., Ikeda, M., and Kurimoto, M., Interleukin-18 protects mice against acute herpes simplex virus type 1 infection. J. Virol., 73, 2401-2409 (1999).
35. Harandi, A. M., Svennerholm, B., Holmgren, J., and Eriksson, K., Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of acquired gamma interferon-mediated protective immunity. J. Virol., 75, 6705-6709 (2001).
36. Humphrey, B. D., Huang, N., and Klasing, K. C., Rice expressing lactoferrin and lysozyme has antibiotic-like properties when fed to chicks. J. Nutr., 132, 1214-1218 (2002).
37. Spurlock, M .E., Regulation of metabolism and growth during immune challenge: An overview of cytokine function. J. Anim. Sci., 75, 1773-1783 (1997).
38. Ebrahimi, B., Dutia, B. M., Brownstein, D. G., and Nash, A. A., Murine gammaherpesvirus-68 infection causes multi-organ fibrosis and alters leukocyte trafficking in interferon-γ receptor knockout mice. Am. J. Pathol., 158, 2117-2125 (2001).